Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Comment by wagyusteakon Aug 19, 2020 1:16pm
68 Views
Post# 31429309

RE:Long-term compounder

RE:Long-term compounder
EbbFlow88 wrote: This company's story is just beginning to unfold. I'm relatively new as I've been a shareholder for about 6 months but goodman is a great allocator in my opinion. He has proven that many times.

He is extremely patient and has taken him a long time to find this deal, which gives me confidence he knows exactly what he's doing and the great potential here. I believe it will be a long-term compounder but will not be an overnight success. Buy this one and put it away. Check back in 10 years and I bet you will be impressed with your returns.


just want to give you a warning, some naysayers who have been holding this for about 4-6 years and boought the stock at $10 will disagree with you. I'm holding this for about 4.5 years now and I agree with you.
Bullboard Posts